MedPath

The effect of exercise and supplementation of ellagic acid on obesity

Phase 3
Conditions
Obesity.
Overweight and obesity
Registration Number
IRCT20191020045170N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
40
Inclusion Criteria

Having weight changes of less than 2kg in the last 6 months
Body mass index (BMI) greater than 30 kg / m 2
No history of any bone, cardiovascular, respiratory, liver, kidney, brain or hormonal disease
Women in districts 1-6 of Tehran
Age range between 30 and 45 years

Exclusion Criteria

Alcohol and cigarette consumption a week before the protocol
Pre-protocol skeletal injuries
Sensitivity to supplement or placebo
Having a medical prohibition letter about exercise or supplementation
Pregnancy or lactation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum levels of GPx. Timepoint: Before intervention and 48 hours after intervention (Exercise and supplementation). Method of measurement: Colorimetric GPX assay kit, abcam 102530, Germany.;Malondialdehyde (MDA). Timepoint: Before intervention and 48 hours after intervention (Exercise and supplementation). Method of measurement: Colorimetric MDA assay Kit, abcam 118970, Germany.;Total antioxidant capacity serum level. Timepoint: Before intervention and 48 hours after intervention (Exercise and supplementation). Method of measurement: Using FRAP method and 592 nm wavelength spectrophotometer using ELISA (Mercodia, Sweden).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath